Free US stock support and resistance levels with price projection models for strategic trading decisions. Our technical levels are calculated using sophisticated algorithms that identify the most significant price barriers.
Coherus Oncology Inc. (CHRS) is trading at $1.98 as of the current date, marking a 4.21% gain in recent trading sessions. This analysis outlines key technical levels, sector context, and potential trading scenarios for the biotech stock, with a focus on observable market dynamics rather than speculative forecasts. No recent earnings data is available for CHRS as of this analysis, so recent price action has been driven largely by technical trading flows and broader sector sentiment rather than qu
Coherus (CHRS) Stock Pre Market (Rallies) 2026-04-18 - MA Crossover
CHRS - Stock Analysis
4350 Comments
1884 Likes
1
Merve
New Visitor
2 hours ago
You make multitasking look like a magic trick. 🎩✨
👍 39
Reply
2
Ruthlynn
Influential Reader
5 hours ago
I feel like I missed something obvious.
👍 243
Reply
3
Yle
Expert Member
1 day ago
Stop being so ridiculously talented. 🙄
👍 187
Reply
4
Chaka
Regular Reader
1 day ago
So disappointed I missed it. 😭
👍 112
Reply
5
Sunna
Legendary User
2 days ago
This feels like a missed opportunity.
👍 95
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.